Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

The Oncology Institute Inc (TOI)

The Oncology Institute Inc (TOI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

The Oncology Institute Inc 18000 STUDEBAKER ROAD SUITE 800 CERRITOS CA 90703 USA

www.theoncologyinstitute.com Employees: 825 P: 562-735-3226

Sector:

Medical

Description:

The Oncology Institute is involved in providing value-based oncology care. The Oncology Institute, formerly known as DFP Healthcare Acquisitions Corp., is based in NEW YORK.

Key Statistics

Overview:

Market Capitalization, $K 257,758
Enterprise Value, $K 301,218
Shares Outstanding, K 98,381
Float, K 90,019
% Float 91.50%
Short Interest, K 6,950
Short Float 7.06%
Days to Cover 2.84
Short Volume Ratio 0.43
% of Insider Shareholders 8.50%
% of Institutional Shareholders 36.86%

Financials:

Annual Sales, $ 393,410 K
Annual Net Income, $ -64,660 K
Last Quarter Sales, $ 136,560 K
Last Quarter Net Income, $ -16,500 K
EBIT, $ -34,090 K
EBITDA, $ -22,000 K

Growth:

1-Year Return 158.52%
3-Year Return 62.73%
5-Year Return -75.63%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.14 on 11/13/25
Next Earnings Date 03/23/26
Earnings Per Share ttm -0.61
EPS Growth vs. Prev Qtr 6.67%
EPS Growth vs. Prev Year 22.22%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

TOI Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -35.30%
Profit Margin % -16.44%
Debt/Equity -6.21
Price/Sales 0.49
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.13
Interest Coverage -7.62
60-Month Beta 0.14
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar